
A recent retrospective cohort study conducted at a US tertiary care hospital from 2014 to 2019 sheds light on the outcomes of cataract surgery in patients with hepatitis C virus (HCV) seropositivity. Among 11,276 eyes from 6,858 patients, 1.78% tested positive for HCV. Notably, patients with HCV faced a 2.27-fold higher likelihood of surgical complications than their HCV-negative counterparts (2.9% vs. 1.2%). However, both groups achieved excellent best-corrected visual acuity post-surgery. Patients with elevated alanine transaminase levels (>52 U/L) exhibited the highest complication risk.
Like
Save
Share